CPRX Financial Facts
Revenues - government grant: 0Total operating costs and expenses: 1.13M
See Full Income Statement
Commitments and contingencies: 0
Property and equipment, net: 18.28K
See Full Balance Sheet
Catalyst Pharmaceutical Partners Inc. (CPRX) Earnings
|
Expand Research on CPRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +110.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/10/22 | Q222 | N/A | $0.17 | N/A | N/A | $49.22M | N/A | N/A | N/A | ||
| 8/9/21 |  |
Q221 | $0.17 | $0.09 | +$0.08 | $36.4M | $31.51M | N/A |  | | Details |
| 5/10/21 | |
Q121 | $0.11 | $0.09 | +$0.02 | $30.2M | $32.1M | N/A | | | Details |
3/16/21  |
|
Q420 | N/A | $0.09 | N/A | N/A | $30.35M | N/A | N/A | N/A | |
| 11/9/20 | |
Q320 | $0.42 | $0.10 | +$0.32 | $29.2M | $31.49M | N/A | | | Details |
| 8/10/20 | |
Q220 | $0.09 | $0.08 | +$0.01 | $29.6M | $29.48M | N/A | | | Details |
| 5/11/20 | |
Q120 | $0.10 | $0.09 | +$0.01 | $29.1M | $31.46M | N/A | | | Details |
| 3/16/20 | |
Q419 | $0.07 | $0.10 | -$0.03 | $30M | $29.4M | N/A | | | Details |
